These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6056088)

  • 1. [Biometric study of the changes of the mechanical phases of the cardiac cycle induced by intravenous desacetyl-lanatoside C in normal humans].
    Sala G; Rocca E; Riva D; Foresti A
    Minerva Cardioangiol; 1967 Jun; 15(6):424-9. PubMed ID: 6056088
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of lanatoside C on the normal heart].
    Polis O; De Keyser JW; Lenaers A; Smets P; Balthazar E; Jank K; Vancrombreucq JC; Denolin H
    Rev Eur Etud Clin Biol; 1971 Dec; 16(10):992-1001. PubMed ID: 5139844
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience on Desacetyl-lanatoside C].
    Fimiani R; Silvestroni A
    Minerva Cardioangiol; 1967 Mar; 15(5):353-7. PubMed ID: 5603841
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative evaluation, by the polygraphic method, of the effect of proscillaridine A and desacetyl-lanatoside C in normal subjects].
    Jacono A; De Divitiis O; Vitale P; Giordano F
    Minerva Cardioangiol; 1967 Sep; 15(9):570-8. PubMed ID: 5629534
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the onset of the effect of G-strophanthin and lanatoside C in healthy persons].
    Hamet A; Pidrman V; Mihulová L
    Vnitr Lek; 1969 Mar; 15(3):209-15. PubMed ID: 5780040
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of the inotropic effect of lanatoside C on the cardiac function and mechanism of mitral valve closure in patients with sinus rhythm].
    Lorente P; Bourthoumeiux A; Skoufas P; Motte G; Pernot PG
    Arch Mal Coeur Vaiss; 1970 May; 63(5):720-39. PubMed ID: 4989373
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of lanatoside C on right ventricular function and pulmonary circulation in patients with mitral stenosis.
    Dubiel JP; Kolasińska-Kloch W
    Acta Med Pol; 1981; 22(1):59-74. PubMed ID: 7270247
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ballistocardiographic studies on the effect of lanatoside C on the normal heart].
    Lydtin H; Schnelle K; Zöllner N
    Z Gesamte Exp Med Einschl Exp Chir; 1965; 139(7):651-62. PubMed ID: 5887475
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of a new cardiotonic drug, desacetyl-lanatoside C].
    Warembourg H; Bertrand ME; Ducloux G
    Lille Med; 1972 Feb; 17():Suppl 2:169-72. PubMed ID: 5034397
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of a new digitalic drug: desacetyl-lanatoside C].
    Faivre G; Djaidane A
    Therapeutique; 1972 Feb; 48(2):111-5. PubMed ID: 5049320
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the use of desacetyl-lanatoside C in therapy of uncompensated heart diseases. Clinical contribution].
    Vercillo L; Rossi C; Vergallo L
    Minerva Med; 1965 Sep; 56(74):3172-5. PubMed ID: 5319422
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with desacetyl-lanatoside C in treatment and in preparation for surgery of surgical heart disease patients].
    Stocco M; Grasso A
    Minerva Chir; 1965 Sep; 20(17):757-64. PubMed ID: 5852632
    [No Abstract]   [Full Text] [Related]  

  • 13. [Desacetyl-lanatoside-C in heart diseases].
    Apparete F; Pugliese F
    Minerva Cardioangiol; 1965 Oct; 13(10):692-6. PubMed ID: 5854401
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasmatic concentrations of tritiated desacetyl-lanatoside C after intravenous and intramuscular injections in cardiopathic subjects].
    Foresti A; Damascelli B; Formentini A; Riva D
    Atti Soc Ital Cardiol; 1968; 2():211-3. PubMed ID: 4887456
    [No Abstract]   [Full Text] [Related]  

  • 15. [The bradycardiac effect of oral administration of an overload of desacetyl-lanatoside C].
    Pavesi V; Bianchi G
    Minerva Med; 1966 Jun; 57(45):2075-8. PubMed ID: 5939220
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of the maintenance dosage on urinary elimination of an average standard digitalization dose of tritiated desacetyl-lanatoside C in normal subjects and in fibrillating cardiopathic subjects].
    Damascelli B; Roncoroni L; Cova N; Pavesi V; Bianchi G
    Minerva Cardioangiol; 1967 Jun; 15(6):398-403. PubMed ID: 6056084
    [No Abstract]   [Full Text] [Related]  

  • 17. [On some immediate effects of the intravenous administration of desacetyl-lanatoside C in aged subjects].
    Tàmmaro AE; Baldoli C
    Clin Ter; 1967 Jan; 40(2):157-61. PubMed ID: 5600177
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the advantages of the use of desacetyl-lanatoside C in cardiokinetic therapy].
    De Magistris L; Menegazzo G
    Minerva Med; 1967 Feb; 58(13):482-8. PubMed ID: 6021619
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of the use of desacetyl-lanatoside C in the treatment of cardiac insufficiency].
    Bersi M; Bocchiola M
    Minerva Cardioangiol; 1970 Jul; 18(7):449-56. PubMed ID: 5510027
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of ultrasonocardiography in the evaluation of the effects of drugs on myocardial functioning].
    Lapińska K
    Kardiol Pol; 1975; 18(5):439-46. PubMed ID: 1185925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.